{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:49:35Z","timestamp":1793836175215,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA24916"],"award-info":[{"award-number":["R01CA24916"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA247573"],"award-info":[{"award-number":["U01CA247573"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bioengineered probiotics enable new opportunities to improve colorectal cancer (CRC) screening, prevention and treatment. Here, first, we demonstrate selective colonization of colorectal adenomas after oral delivery of probiotic\n                    <jats:italic>E. coli<\/jats:italic>\n                    Nissle 1917 (EcN) to a genetically-engineered murine model of CRC predisposition and orthotopic models of CRC. We next undertake an interventional, double-blind, dual-centre, prospective clinical trial, in which CRC patients take either placebo or EcN for two weeks prior to resection of neoplastic and adjacent normal colorectal tissue (ACTRN12619000210178). We detect enrichment of EcN in tumor samples over normal tissue from probiotic-treated patients (primary outcome of the trial). Next, we develop early CRC intervention strategies. To detect lesions, we engineer EcN to produce a small molecule, salicylate. Oral delivery of this strain results in increased levels of salicylate in the urine of adenoma-bearing mice, in comparison to healthy controls. To assess therapeutic potential, we engineer EcN to locally release a cytokine, GM-CSF, and blocking nanobodies against PD-L1 and CTLA-4 at the neoplastic site, and demonstrate that oral delivery of this strain reduces adenoma burden by ~50%. Together, these results support the use of EcN as an orally-deliverable platform to detect disease and treat CRC through the production of screening and therapeutic molecules.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-44776-4","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T09:02:12Z","timestamp":1705741332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":213,"title":["Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia"],"prefix":"10.1038","volume":"15","author":[{"given":"Candice R.","family":"Gurbatri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgette A.","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vrbanac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-2770","authenticated-orcid":false,"given":"Jongwon","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-133X","authenticated-orcid":false,"given":"Courtney","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0926-9394","authenticated-orcid":false,"given":"Samuel R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YoungUk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Sivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4582-2895","authenticated-orcid":false,"given":"Kyu","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8618-3669","authenticated-orcid":false,"given":"Fereshteh","family":"Zandkarimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Lia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamsin R. M.","family":"Lannagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8807-2441","authenticated-orcid":false,"given":"Tongtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1717-4870","authenticated-orcid":false,"given":"Hiroki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Q.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Sammour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lito","family":"Papanicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Fitzsimmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Kaazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8172-9140","authenticated-orcid":false,"given":"Amanda","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion A.","family":"Gouskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Marker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1067-6226","authenticated-orcid":false,"given":"Cheri","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0657-0528","authenticated-orcid":false,"given":"Nicholas","family":"Arpaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-9124","authenticated-orcid":false,"given":"Daniel L.","family":"Worthley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8955-2017","authenticated-orcid":false,"given":"Susan L.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2713-7659","authenticated-orcid":false,"given":"Tal","family":"Danino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,20]]},"reference":[{"key":"44776_CR1","doi-asserted-by":"crossref","unstructured":"Mazzolini, R. et al. Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms. Nat. Biotechnol. 41, 1089\u20131098 (2023).","DOI":"10.1038\/s41587-022-01584-9"},{"key":"44776_CR2","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1016\/j.cell.2022.06.050","volume":"185","author":"BJ Russell","year":"2022","unstructured":"Russell, B. J. et al. Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes. Cell 185, 3263\u20133277. e3215 (2022).","journal-title":"Cell"},{"key":"44776_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mib.2019.09.005","volume":"50","author":"T Whitfill","year":"2019","unstructured":"Whitfill, T. & Oh, J. Recoding the metagenome: microbiome engineering in situ. Curr. Opin. Microbiol. 50, 28\u201334 (2019).","journal-title":"Curr. Opin. Microbiol."},{"key":"44776_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrc2934","volume":"10","author":"NS Forbes","year":"2010","unstructured":"Forbes, N. S. Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10, 785\u2013794 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"44776_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coisb.2017.05.009","volume":"5","author":"T Chien","year":"2017","unstructured":"Chien, T., Doshi, A. & Danino, T. Advances in bacterial cancer therapies using synthetic biology. Curr. Opin. Syst. Biol. 5, 1\u20138 (2017).","journal-title":"Curr. Opin. Syst. Biol."},{"key":"44776_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","volume":"51","author":"MT-Q Duong","year":"2019","unstructured":"Duong, M. T.-Q., Qin, Y., You, S.-H. & Min, J.-J. Bacteria-cancer interactions: bacteria-based cancer therapy. Exp. Mol. Med. 51, 1\u201315 (2019).","journal-title":"Exp. Mol. Med."},{"key":"44776_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.add9667","volume":"378","author":"CR Gurbatri","year":"2022","unstructured":"Gurbatri, C. R., Arpaia, N. & Danino, T. Engineering bacteria as interactive cancer therapies. Science 378, 858\u2013864 (2022).","journal-title":"Science"},{"key":"44776_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.15252\/msb.20167416","volume":"13","author":"KNM Daeffler","year":"2017","unstructured":"Daeffler, K. N. M. et al. Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation. Mol. Syst. Biol. 13, 923 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"44776_CR9","doi-asserted-by":"publisher","first-page":"eaao2586","DOI":"10.1126\/scitranslmed.aao2586","volume":"10","author":"N Mao","year":"2018","unstructured":"Mao, N., Cubillos-Ruiz, A., Cameron, D. E. & Collins, J. J. Probiotic strains detect and suppress cholera in mice. Sci. Transl. Med. 10, eaao2586 (2018).","journal-title":"Sci. Transl. Med."},{"key":"44776_CR10","doi-asserted-by":"publisher","first-page":"959441","DOI":"10.3389\/fbioe.2022.959441","volume":"10","author":"CM Robinson","year":"2022","unstructured":"Robinson, C. M., Short, N. E. & Riglar, D. T. Achieving spatially precise diagnosis and therapy in the mammalian gut using synthetic microbial gene circuits. Front. Bioeng. Biotechnol. 10, 959441 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"44776_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14012-5","volume":"11","author":"C Munck","year":"2020","unstructured":"Munck, C., Sheth, R. U., Freedberg, D. E. & Wang, H. H. Recording mobile DNA in the gut microbiota using an Escherichia coli CRISPR-Cas spacer acquisition platform. Nat. Commun. 11, 95 (2020).","journal-title":"Nat. Commun."},{"key":"44776_CR12","doi-asserted-by":"publisher","first-page":"eabm6038","DOI":"10.1126\/science.abm6038","volume":"376","author":"F Schmidt","year":"2022","unstructured":"Schmidt, F. et al. Noninvasive assessment of gut function using transcriptional recording sentinel cells. Science 376, eabm6038 (2022).","journal-title":"Science"},{"key":"44776_CR13","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA: Cancer J. 70, 7\u201330 (2020).","journal-title":"CA: Cancer J."},{"key":"44776_CR14","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1001\/jama.2016.3332","volume":"315","author":"JS Lin","year":"2016","unstructured":"Lin, J. S. et al. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. Jama 315, 2576\u20132594 (2016).","journal-title":"Jama"},{"key":"44776_CR15","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa054967","volume":"355","author":"J Regula","year":"2006","unstructured":"Regula, J. et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N. Engl. J. Med. 355, 1863\u20131872 (2006).","journal-title":"N. Engl. J. Med."},{"key":"44776_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5009\/gnl19306","volume":"14","author":"GS Kew","year":"2020","unstructured":"Kew, G. S. & Koh, C. J. Strategies to improve persistent adherence in colorectal cancer screening. Gut Liver 14, 546 (2020).","journal-title":"Gut Liver"},{"key":"44776_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.66","volume":"8","author":"J Nian","year":"2017","unstructured":"Nian, J. et al. Diagnostic accuracy of methylated SEPT9 for blood-based colorectal cancer detection: a systematic review and meta-analysis. Clin. Transl. Gastroenterol. 8, e216 (2017).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"44776_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"L Song","year":"2017","unstructured":"Song, L., Jia, J., Peng, X., Xiao, W. & Li, Y. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: a meta-analysis. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"44776_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bmb\/ldw028","volume":"119","author":"J Burn","year":"2016","unstructured":"Burn, J. & Sheth, H. The role of aspirin in preventing colorectal cancer. Br. Med. Bull. 119, 17\u201324 (2016).","journal-title":"Br. Med. Bull."},{"key":"44776_CR20","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","volume":"395","author":"J Burn","year":"2020","unstructured":"Burn, J. et al. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet 395, 1855\u20131863 (2020).","journal-title":"Lancet"},{"key":"44776_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ijms18010197","volume":"18","author":"I M\u00e1rmol","year":"2017","unstructured":"M\u00e1rmol, I., S\u00e1nchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E. & Rodriguez Yoldi, M. J. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int. J. Mol. Sci. 18, 197 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"44776_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14740\/gr1239","volume":"13","author":"M Ahmed","year":"2020","unstructured":"Ahmed, M. Colon cancer: a clinician\u2019s perspective in 2019. Gastroenterol. Res. 13, 1 (2020).","journal-title":"Gastroenterol. Res."},{"key":"44776_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers14010052","volume":"14","author":"MM Germani","year":"2021","unstructured":"Germani, M. M. & Moretto, R. Immune checkpoint inhibitors in mismatch repair proficient\/microsatellite stable metastatic colorectal cancer patients: Insights from the AtezoTRIBE and MAYA trials. Cancers 14, 52 (2021).","journal-title":"Cancers"},{"key":"44776_CR24","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9, T. et al. Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer. N. Engl. J. Med. 383, 2207\u20132218 (2020).","journal-title":"N. Engl. J. Med."},{"key":"44776_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi, M. et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat. Med. 26, 566\u2013576 (2020).","journal-title":"Nat. Med."},{"key":"44776_CR26","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1128\/AEM.01390-12","volume":"78","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein. Appl. Environ. Microbiol. 78, 7603\u20137610 (2012).","journal-title":"Appl. Environ. Microbiol."},{"key":"44776_CR27","doi-asserted-by":"publisher","first-page":"289ra284","DOI":"10.1126\/scitranslmed.aaa3519","volume":"7","author":"T Danino","year":"2015","unstructured":"Danino, T. et al. Programmable probiotics for detection of cancer in urine. Sci. Transl. Med. 7, 289ra284\u2013289ra284 (2015).","journal-title":"Sci. Transl. Med."},{"key":"44776_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/1751-7915.13523","volume":"13","author":"X Yu","year":"2020","unstructured":"Yu, X., Lin, C., Yu, J., Qi, Q. & Wang, Q. Bioengineered Escherichia coli Nissle 1917 for tumour\u2010targeting therapy. Microb. Biotechnol. 13, 629\u2013636 (2020).","journal-title":"Microb. Biotechnol."},{"key":"44776_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbcan.2013.01.001","volume":"1836","author":"M Zeineldin","year":"2013","unstructured":"Zeineldin, M. & Neufeld, K. L. More than two decades of APC modeling in rodents. Biochim. Biophys. Acta (BBA) Rev. Cancer 1836, 80\u201389 (2013).","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"44776_CR30","doi-asserted-by":"crossref","unstructured":"Kwong, L. N. & Dove, W. F. APC and its modifiers in colon cancer. Adv. Exp. Med. Biol. 656, 85\u2013106 (2009).","DOI":"10.1007\/978-1-4419-1145-2_8"},{"key":"44776_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1021\/sb3000639","volume":"1","author":"T Danino","year":"2012","unstructured":"Danino, T., Lo, J., Prindle, A., Hasty, J. & Bhatia, S. N. In vivo gene expression dynamics of tumor-targeted bacteria. ACS Synth. Biol. 1, 465\u2013470 (2012).","journal-title":"ACS Synth. Biol."},{"key":"44776_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature18930","volume":"536","author":"MO Din","year":"2016","unstructured":"Din, M. O. et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature 536, 81\u201385 (2016).","journal-title":"Nature"},{"key":"44776_CR33","doi-asserted-by":"publisher","first-page":"eaax0876","DOI":"10.1126\/scitranslmed.aax0876","volume":"12","author":"CR Gurbatri","year":"2020","unstructured":"Gurbatri, C. R. et al. Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci. Transl. Med. 12, eaax0876 (2020).","journal-title":"Sci. Transl. Med."},{"key":"44776_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano, C. et al. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli. Nature 580, 269\u2013273 (2020).","journal-title":"Nature"},{"key":"44776_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-07876-8","volume":"21","author":"M Oliero","year":"2021","unstructured":"Oliero, M. et al. Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains. BMC Cancer 21, 1\u201310 (2021).","journal-title":"BMC Cancer"},{"key":"44776_CR36","first-page":"e00591","volume":"5","author":"A Wallenstein","year":"2020","unstructured":"Wallenstein, A. et al. ClbR is the key transcriptional activator of colibactin gene expression in Escherichia coli. MSphere 5, e00591\u201300520 (2020).","journal-title":"MSphere"},{"key":"44776_CR37","doi-asserted-by":"publisher","first-page":"e0280499","DOI":"10.1371\/journal.pone.0280499","volume":"18","author":"A Kalantari","year":"2023","unstructured":"Kalantari, A. et al. Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster. PLoS One 18, e0280499 (2023).","journal-title":"PLoS One"},{"key":"44776_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13336-6","volume":"10","author":"P Praveschotinunt","year":"2019","unstructured":"Praveschotinunt, P. et al. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nat. Commun. 10, 1\u201314 (2019).","journal-title":"Nat. Commun."},{"key":"44776_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","volume":"2","author":"CL Ho","year":"2018","unstructured":"Ho, C. L. et al. Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nat. Biomed. Eng. 2, 27\u201337 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"44776_CR40","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/IAI.01449-05","volume":"74","author":"A Grabig","year":"2006","unstructured":"Grabig, A. et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2-and toll-like receptor 4-dependent pathways. Infect. Immun. 74, 4075\u20134082 (2006).","journal-title":"Infect. Immun."},{"key":"44776_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/gutjnl-2017-315920","volume":"68","author":"TR Lannagan","year":"2019","unstructured":"Lannagan, T. R. et al. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut 68, 684\u2013692 (2019).","journal-title":"Gut"},{"key":"44776_CR42","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/jnci\/djt300","volume":"105","author":"J Ahn","year":"2013","unstructured":"Ahn, J. et al. Human gut microbiome and risk for colorectal cancer. J. Natl Cancer Inst. 105, 1907\u20131911 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"44776_CR43","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1053\/j.gastro.2019.12.018","volume":"158","author":"T Kaltenbach","year":"2020","unstructured":"Kaltenbach, T. et al. Endoscopic removal of colorectal lesions\u2014recommendations by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 158, 1095\u20131129 (2020).","journal-title":"Gastroenterology"},{"key":"44776_CR44","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o, J. L. et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature 611, 810\u2013817 (2022).","journal-title":"Nature"},{"key":"44776_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore, G. D. et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 579, 567\u2013574 (2020).","journal-title":"Nature"},{"key":"44776_CR46","doi-asserted-by":"publisher","first-page":"18321","DOI":"10.1073\/pnas.1406199111","volume":"111","author":"CM Dejea","year":"2014","unstructured":"Dejea, C. M. et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl Acad. Sci. USA 111, 18321\u201318326 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"44776_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0923-2508(02)00007-4","volume":"154","author":"G Blum-Oehler","year":"2003","unstructured":"Blum-Oehler, G. et al. Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples. Res. Microbiol. 154, 59\u201366 (2003).","journal-title":"Res. Microbiol."},{"key":"44776_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-3-60","volume":"3","author":"P Padmanabhan","year":"2013","unstructured":"Padmanabhan, P., Grosse, J., Asad, A. B. M. A., Radda, G. K. & Golay, X. Gastrointestinal transit measurements in mice with 99m Tc-DTPA-labeled activated charcoal using NanoSPECT-CT. EJNMMI Res. 3, 1\u20138 (2013).","journal-title":"EJNMMI Res."},{"key":"44776_CR49","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jcp.56.9.651","volume":"56","author":"J Lawrence","year":"2003","unstructured":"Lawrence, J. et al. Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin. J. Clin. Pathol. 56, 651\u2013653 (2003).","journal-title":"J. Clin. Pathol."},{"key":"44776_CR50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1021\/acssynbio.0c00497","volume":"10","author":"T Chien","year":"2020","unstructured":"Chien, T., Jones, D. R. & Danino, T. Engineered bacterial production of volatile methyl salicylate. ACS Synth. Biol. 10, 204\u2013208 (2020).","journal-title":"ACS Synth. Biol."},{"key":"44776_CR51","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3389\/fmicb.2018.02241","volume":"9","author":"R Qi","year":"2018","unstructured":"Qi, R., Pfeifer, B. A. & Zhang, G. Engineering heterologous production of salicylate glucoside and glycosylated variants. Front. Microbiol. 9, 2241 (2018).","journal-title":"Front. Microbiol."},{"key":"44776_CR52","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","volume":"25","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury, S. et al. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat. Med. 25, 1057\u20131063 (2019).","journal-title":"Nat. Med."},{"key":"44776_CR53","doi-asserted-by":"publisher","first-page":"762341","DOI":"10.3389\/fimmu.2021.762341","volume":"12","author":"D Wang","year":"2021","unstructured":"Wang, D., Zhang, H., Xiang, T. & Wang, G. Clinical application of adaptive immune therapy in MSS colorectal cancer patients. Front. Immunol. 12, 762341 (2021).","journal-title":"Front. Immunol."},{"key":"44776_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh, K. et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat. Rev. Gastroenterol. Hepatol. 16, 361\u2013375 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"44776_CR55","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","volume":"25","author":"JJ Luke","year":"2019","unstructured":"Luke, J. J., Bao, R., Sweis, R. F., Spranger, S. & Gajewski, T. F. WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers. Clin. Cancer Res. 25, 3074\u20133083 (2019).","journal-title":"Clin. Cancer Res."},{"key":"44776_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-59899-z","volume":"10","author":"TW Parker","year":"2020","unstructured":"Parker, T. W. & Neufeld, K. L. APC controls Wnt-induced \u03b2-catenin destruction complex recruitment in human colonocytes. Sci. Rep. 10, 1\u201314 (2020).","journal-title":"Sci. Rep."},{"key":"44776_CR57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ibd.21042","volume":"16","author":"TH Joeres-Nguyen-Xuan","year":"2010","unstructured":"Joeres-Nguyen-Xuan, T. H., Boehm, S. K., Joeres, L., Schulze, J. & Kruis, W. Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers. Inflamm. Bowel Dis. 16, 256\u2013262 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"44776_CR58","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.chom.2022.12.004","volume":"31","author":"Z-P Zou","year":"2023","unstructured":"Zou, Z.-P., Du, Y., Fang, T.-T., Zhou, Y. & Ye, B.-C. Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice. Cell Host Microbe 31, 199\u2013212. e195 (2023).","journal-title":"Cell Host Microbe"},{"key":"44776_CR59","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/bit.21785","volume":"100","author":"YA Yu","year":"2008","unstructured":"Yu, Y. A., Zhang, Q. & Szalay, A. A. Establishment and characterization of conditions required for tumor colonization by intravenously delivered bacteria. Biotechnol. Bioeng. 100, 567\u2013578 (2008).","journal-title":"Biotechnol. Bioeng."},{"key":"44776_CR60","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","volume":"174","author":"N Zmora","year":"2018","unstructured":"Zmora, N. et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174, 1388\u20131405. e1321 (2018).","journal-title":"Cell"},{"key":"44776_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.micinf.2015.01.004","volume":"17","author":"D Ribet","year":"2015","unstructured":"Ribet, D. & Cossart, P. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect. 17, 173\u2013183 (2015).","journal-title":"Microbes Infect."},{"key":"44776_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrmicro2265","volume":"8","author":"MA Croxen","year":"2010","unstructured":"Croxen, M. A. & Finlay, B. B. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8, 26\u201338 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"44776_CR63","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.chom.2016.07.006","volume":"20","author":"J Abed","year":"2016","unstructured":"Abed, J. et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 20, 215\u2013225 (2016).","journal-title":"Cell Host Microbe"},{"key":"44776_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2199-4-11","volume":"4","author":"KC Murphy","year":"2003","unstructured":"Murphy, K. C. & Campellone, K. G. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol. Biol. 4, 1\u201312 (2003).","journal-title":"BMC Mol. Biol."},{"key":"44776_CR65","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1038\/nprot.2006.446","volume":"1","author":"C Becker","year":"2006","unstructured":"Becker, C., Fantini, M. & Neurath, M. High resolution colonoscopy in live mice. Nat. Protoc. 1, 2900\u20132904 (2006).","journal-title":"Nat. Protoc."},{"key":"44776_CR66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-019-0965-1","volume":"568","author":"A Almeida","year":"2019","unstructured":"Almeida, A. et al. A new genomic blueprint of the human gut microbiota. Nature 568, 499\u2013504 (2019).","journal-title":"Nature"},{"key":"44776_CR67","unstructured":"Yuqin Dai, J. J. H. Discovery Metabolomics LC\/MS Methods Optimized for Polar Metabolites (Agilent Technologies, Inc., 2019)."},{"key":"44776_CR68","doi-asserted-by":"crossref","unstructured":"Smith, C. A., Want, E. J., O\u2019Maille, G., Abagyan, R. & Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779\u2013787 (2006).","DOI":"10.1021\/ac051437y"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44776-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44776-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44776-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T12:03:17Z","timestamp":1706011397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44776-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["44776"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-44776-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,20]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.D., N.A., D.L.W., S.L.W. and C.R.G. have financial interest in GenCirq Inc. T.D., D.L.W., S.L.W. and C.R.G. have filed a provisional patent application (\u201cColorectal Cancer Screening, Prevention, And Treatment With Engineered Probiotics\u201d) with the US Patent and Trademark Office related to this manuscript. The remaining authors have no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"646"}}